These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16329672)

  • 1. Immunoadsorption in dilated cardiomyopathy.
    Felix SB
    Ernst Schering Res Found Workshop; 2006; (55):353-61. PubMed ID: 16329672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoadsorption in dilated cardiomyopathy.
    Staudt A; Felix SB
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB; Staudt A
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of cardiac function after immunoadsorption in patients with dilated cardiomyopathy.
    Felix SB; Staudt A; Friedrich GB
    Autoimmunity; 2001; 34(3):211-5. PubMed ID: 11908780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-specific immunoadsorption in patients with dilated cardiomyopathy: mechanisms and clinical effects.
    Felix SB; Staudt A
    Int J Cardiol; 2006 Sep; 112(1):30-3. PubMed ID: 16860418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunoadsorption for treatment of dilated cardiomyopathy].
    Felix SB; Dörr M; Herda LR; Beug D; Staudt A
    Internist (Berl); 2008 Jan; 49(1):51-6. PubMed ID: 18071664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR; Felix SB; Staudt A
    Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadsorption therapy in dilated cardiomyopathy.
    Felix SB; Beug D; Dörr M
    Expert Rev Cardiovasc Ther; 2015 Feb; 13(2):145-52. PubMed ID: 25494978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
    Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
    J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
    Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
    Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta
    Camino M; Morales MD
    Front Biosci (Elite Ed); 2019 Jan; 11(1):102-108. PubMed ID: 30468641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL; Tona F; Bottaro S; Vinci A; Dequal G; Daliento L; Thiene G; Iliceto S
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies.
    Trimpert C; Herda LR; Eckerle LG; Pohle S; Müller C; Landsberger M; Felix SB; Staudt A
    Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
    Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
    J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in dilated cardiomyopathy induce vascular endothelial growth factor expression in cardiomyocytes.
    Saygili E; Noor-Ebad F; Schröder JW; Mischke K; Saygili E; Rackauskas G; Marx N; Kelm M; Rana OR
    Biochem Biophys Res Commun; 2015 Sep; 465(1):119-24. PubMed ID: 26248134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption.
    Felix SB; Staudt A; Landsberger M; Grosse Y; Stangl V; Spielhagen T; Wallukat G; Wernecke KD; Baumann G; Stangl K
    J Am Coll Cardiol; 2002 Feb; 39(4):646-52. PubMed ID: 11849864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy.
    Dörffel WV; Felix SB; Wallukat G; Brehme S; Bestvater K; Hofmann T; Kleber FX; Baumann G; Reinke P
    Circulation; 1997 Apr; 95(8):1994-7. PubMed ID: 9133505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
    Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ
    Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure.
    Ikeda U; Kasai H; Izawa A; Koyama J; Yazaki Y; Takahashi M; Higuchi M; Koh CS; Yamamoto K
    Curr Cardiol Rev; 2008 Aug; 4(3):219-22. PubMed ID: 19936198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.